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We report a mutation in a case of epiderm.olytic hyperker-
atosis that results in a proline for alanine substitution in the 
residue position 12 of the 1A subdomain of the keratin 10 
chain (codon 158). The disease phenotype is consistent 
with the inappropriate substitution of a proline near the 
begimung of the rod domain, because it is likely to seriously . 
disrupt the structural organization of coiled-coiltnolecules 
within keratin intermediate filaments. Mutations/substi-
E p idermo lyti c hyperkeratosis (E HK) is a rare autosoma l do minant disorder affecting the stru ctural integrity of th e supra basal layers of human epidermis. E HK is charac te ri zed by abnormal keratin interm ediate filam ent (KIF) clumping , cell lys is of the spino us and especially the granular layers, 
hyperpro li feration, and a defective stratum corneum (Ishida-Yamamoto 
ct nl, 1992; D iGiovanna and Bale , 1994a , b; Huber ct a/, I 994; C hipev 
et a/, 1996). R ecent studies have estab lished that E HK is caused by 
mutati ons in e ith er the keratin l or the 10 gene, w hi ch result in 
inappropri ate amino acid substitutions in th e K 1 or K1 0 proteins 
(Cheng ct a/, '1992; C hipev ct a/, 1992; R o thnagel et a/, 1992; Bale 
et nl, 1993; Ste in ert, 1993; Compton, 1994; Fuc hs and W eber, 1994; 
M cLean and La ne, 1995; Parry and Ste ine rt, 1995; Fuchs, 1996; Korge 
and Krieg, 1996; Ste inert et a/, 1997). Most of the deleterious 
substitutions reside in the begi nn i11g or end of the rod domain segments 
of these chains. C li nicaUy, EHK has been dassified in to two types 
depending o n th e presence or absence of palmopla ntar involvem ent, 
and each Lype has been subdivided into several sub types according to 
the nature and severity of scaling (DiGiova nna and Bale, l994a, b) . 
Mutation / cli ni ca l ph enotype correlatio ns available to date suggest that 
the palm -sole sub types are due primarily to K1 gene d efec ts and th e 
nonpalm -sole subtypes are du e to Kl O gene defects (DiGiovanna and 
Bale, 1994a, b) . In this paper, we descri be a case of EHK, classified as 
no npalm-sole-2, caused by a novel substi tu tion A158P located in th e 
beginning of the lA do m ain segme nt (A12P). 
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tutions in this position have not been reported in any ker-
atin disease. Position 12 is an alanine in all intermediate 
filatnent chains, and lies in the outer b heptad position of 
the coiled-coil. In vitro peptide interference assembly assays 
revealed that substitutions that alter residue size or charge 
at this position primarily interfere with keratin filament 
elongation. Key IVOI'ds: keratin intermediate filament stmctlll'ei 
type I lwratiu. J Invest Dermatol109:692-694, 1997 
MATER IALS ANI METHODS 
Source of DNA DNA was iso loted as desc ribed (Chipev et nl, 1994 ; Yang 
et rd, 1994) from freshl y drawn blood obtained fi·om both afrected and unafrectcd 
fu mily members. Genomic DNA was also extracted from 50 unrelated indi vidu:tls 
fi·om the normal popula tion and used as contro ls. 
Direct polyn1erasc chain reaction atnp lifi cation and sequencing of the 
keratin 10 gene The oligon ucleotide primers used for the ampl ify ing cxo 11 
1 of KI O were: H(+) , 5'-TTAGGAGGTTTTGGTGGAGGTAGCTTTCGT-
3'; H(+ +) 5'-CGTGGAAGCTATGGAAGTAGCTTT-3'; H(-), 5'-CAT G-
GACAAGATACT TAAAG TGGAT-3' . R.eamplifi ca rion was carried out wi th 
the primers H(+ +)/ 1-l (-). Primer H(-) was also used as a seque11 cing pri111e r, 
using the single-stranded binding protein (Un ited States Biochemical, lcveland, 
O H) (Chipev et nl, 1994). 
IUF assembly assay with synthetic pcptides A peptide cocTesponding to 
the first '18 res idues of the I A segment of the wild- type human I< 1.0 
chain (:unino acids 147-164, f sequence RVTQMN LND I1... LASYLDKV), and 
substitu ted peptides of ahnine12threonine (A l 2T) and A 12D ha ve been made 
previously (Steinert ct nl, 1993b). Additional new peptides with the fo ll owing 
substitu tions were made and purified: A'I2P, A 12G, A 12 L, Al2 V, A 121, A"I2Y, 
A 12$, and A 1. 2K. These were added in a 2-fold molar excess ducing the 
assembly react.ion of KI / KJ O KIF (0.8 mg per ml) (Ste inert cl a/, 1993a, b). 
T he reverse disassembly assay was carri ed out by adding the peptidcs to 
preform ed K1/ K1 0 KIF and incubating fo r 60 min ar 37°C. The resu lrs on 
Kl F integrity were exami11 ed by electron microscopy to llowing nega tive stain ing 
as described previously (Chi pev cl nl, 1992; Steinert cl nl, 1993a, b). Statistical 
cb ta on the lengths of I 00-125 indi vidua l Kl F were measured usi11 g a 111ap 
measuring device (Steinert c/ nl, 1976) . 
lliSVLTS AND D ISCUSS ION 
Clinical description of family EHK-KZ T his three-generati o n 
J apa.nese £1 mily consisted o ftvvo pati ents and five unaffected indi vidu als 
(Fig la). T he diagnosis of EHK was confirm ed by histopa th o logic 
analyses of skin biopsy specim ens of patien t 111 -2. T his 17 -y-old 
boy had brownish w c;nkled, encrusted hyperke ratosis and erosio ns 
thro ugho ut b.i s trunk and extrem.i ties, especially o n fl exural areas, fi·om 
birth . The lesio ns often give un p leasant odo rs. 1-lis mother has the 
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Figure 1. Characteristics of family EHK-KZ. (a) Pedigree of the EHK-KZ. (b) DNA sequences showing G to C change, which introduces an A 12P amino 
acid substitution in codon 158. (c) SerF I digestio n of polymerase chain reaction- amplified DNA of the family members. This mutati.on abolishes a SerF I si te in 
the patients. Only the affected individuals show the undigested 413-bp fragment. 
Figure 2. The A12P mutation alte rs the structural properties of KIF. 
Using an established i11 vi tm assembly assay, a I :2 molar ratio of all 18-residue 
K I 0 peptide o f wil d-type sequence severely interferes with Kl / Kl 0 K.l F 
assembly (b), but a peptide bearing the A 121' substi tu tio n seen in this f.1 m.ily 
does not interfere (c). (a) Control KIF. Scale bars, I 00 nm . 
same skin les.ions; the deceased grand £:1ther-i n-bw was reported to 
have had similar cli ni ca l fea tures. The patients were not etythrodenni c 
and had no lesions on either pa lms or soles, and so were classified 
as the nonpalm-so le-2 type (DiGiovan na and Bale, 1994a). Light 
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Figure 3. Alanine in residue position 12 of the 1A rod domain is essential 
for n1aintenauce of KIF length. Peptidcs of the indicated substitutions were 
rested in the i11 vilm Kl F assembly assay as above . At least 100 Kl F particles 
were mcosured from negative stained images of each reaction to determine 
average lengths ± SD. Open bal', wi ld-type K1 / K'l 0 K IF asse mbled in absence 
of added peptides; black bar, KIF assembled in presence of A.12P peptide, bearing 
the mutation reported here; gray bnl's, vario us other amino acid substituti ons as 
marked. Note that the wild-type peptide A'l 2A did not allow formation of 
filamentous particles (Fig 2b) . 
microscopi c examination revealed E HK Jjmjted to the upper part of 
the epidermis. 
Identification of an alanine to proline substitution in the begin-
ning of the lA rod dmnain segtnent We found no sequence 
variations from normal in all exons of the Kl gene in the aiTec ted 
persons II-4 and Ill-2; however, vve found in th e pati ents a single 
nucleotide substitution in one allele of codon 158 in exon 1 of the 
KlO gene (GCT to CCT) so that the sequ ence gel of Fig 11! shows 
both a wi ld-type G and a 1nutant C in position ·t of this codon. The 
mutant allele encodes a proline residue instead of a wild- type alanine 
residu e in positi on :12 of t~1e lA rod domain segment. This nu cleotide 
substitution destroys a ScrFJ restriction enzyme site (CCNGG) , whi ch 
was then used as a test for th e presence of the mutation in polymerase 
chain rea tion-ampbfied DNA . In this analysis, the normal alleles yield 
fi·agments of213 bp and 200 bp, but the affected allele yields a fragment 
of 413 bp, so that only patients ll-4 and lll -2 yield bands at 413 as 
well as at 213 and 200 bp (Fig lc). Because none of the other 
unaffected family members and none of th e 50 o ther unrelated 
unaflected persons display th e ScrF1 undi ge ted fi·agment, the G to C 
substitution in the aiTected persons represents th e mutation. 
No previous reports of mutations/substitutions have been reported 
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in position 12 of the 1A rod domain in any keratin chain for an y 
keratin disorder (Steinert et al, 1997) . A change in this position, 
however, is expected to ca use disease because it is .located nea r the 
ovedap window of the fi rst severai residues of th e 1A rod domain and 
the last severai residues of the 2B rod domain th at is thought to occur 
between in-row molecules w ithin KIF (Steinert et al, 1993a, b, 1997; 
Fu chs and Weber, 1994; Parry and Steinert, 1995). 
The proline substitution introduces a major structural change 
to the keratin 10 chain U sing an established ilL 11itro KIF assembly 
assay (Ch.ipev eta/, 1992), an 18-residue synthetic peptide corresponding 
to the wild-type K10 sequence severely interfered with the assem.bly 
of K l /KlO KIF in 11itro (Fig 2b) (S teinert et a/, 1993a, b). T his is a 
negative assay for KI F stru cture: this result is thought to occur because 
the peptide competes with the full - length K l 0 chain , thereby inte1fe ring 
with and preventing efficient KIF assembly; however, a synthetic 
pep tide containing an A12P substitution, as identified in tlus £muly, 
did not in terfe re wi th KIF assembly (Fig 2c) , presumably because the 
proline residue signi fica ntly altered structure, so that the peptide could 
no longer effectively compete in the assembly reacti on. Similar data 
(not shown) were obtained when the wild- type and mutan t peptides 
were added to and incubated fo r 1 h with preformed KIF. From this 
we ca n conclude that a full - length K10 chain bearing tlus substitution 
does not allow proper KIF assembly in th e epidenml cell , ultimately 
leading to th e phenotypi c consequences of nonpalm-sole-2 EH K. 
Alanine residue 12 of the 1A domain effects IUF 
elongation R esidue 12 of the lA domain is an aianine residue in 
all IF chains so £1r sequ enced [see Parry and Steinert (1995) fo r 
sequence SllllU1l aries], and thus is one of the most conserved positions 
in this highly conserved domain . T his residue is predicted to occupy 
the b position of the heptad repeat, so that it will lie on the outside 
of a coiled-coil w here it will likely interact with neighboring molecules 
w ithin the KIF superstru cture. In an attempt to address the questi on 
as to why this position is always an alanin e, we made a series of 
synthetic pep tides with a range of substituted res idu es and tested them 
in the K IF assembly reac ti on assay. In most experiments wi th this assay 
to date, the substi tuted peptides resulted in rather dramatic changes in 
KIF morphology, often allowing no Kl F assembly at all (Fig 2c; Chipev 
et al, 1992; Yang eta/, 1996), so th at a simple light-sca tterin g test could 
be utilized (S teinert eta/, 1993b). In most of the peptides used in this 
study, however, cha1;ges in .light sca ttering were minimal , because KIF 
of length ~ 3 IJ.m scatter light efficiently and eq ually (Steinert et. a/, 
1993a). Usi ng a m.ore sensitive electron microscopy assay, we found 
that there were marked changes in the average lengths of the assembled 
KI F, w hich seemed to correlate with res idue size and charge (Fig 3). 
Peptides co ntaining residues such as glycine or serine th at are of a 
comparable or lesser size to alanine, behaved more like the wild-type 
peptide in th at they severely interfered with KIF assembly because 
only short particles formed. Peptides containing substitu ted residu es 
with longer hydroph obi c o r charged side-chains interfered less, so that 
mu ch .longer KIF were allowed to assemble. T hat these substituted 
peptides with a too large or chaxged side-chain in the b heptad positi on 
12 of the lA rod domain segment cannot interfere with KIF assembly 
in 11itro is consistent with the concept that such residu es in th e intact 
K l O chain will interfe re with th e packing of neighboting molecules 
within the KIF. O ur da ta suggest that the affect will be p rimarily upon 
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net KlF length. A proline residue in this position, as identified in tlus 
study, is likely to severely interfere with KI F structure. 
Further studi es now seem warranted to so lve the three-dimensional 
structure of the 1A/2B rod domain overlap window that serves as the 
most sensitive region for disease- causing mutations in keratin disorders. 
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